Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 549 DKK 2.91%
Market Cap: 39B DKK

P/FCFE
Price to FCFE

-63.1
Current
-11.4
Median
24.5
Industry
Lower than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-63.1
=
Market Cap
38.3B DKK
/
FCFE
-614.5m DKK
Market Cap P/FCFE
DK
Zealand Pharma A/S
CSE:ZEAL
38.3B DKK -63.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 114 076.7
US
Abbvie Inc
NYSE:ABBV
357.9B USD 16.3
US
Amgen Inc
NASDAQ:AMGN
164.2B USD 51.2
US
Gilead Sciences Inc
NASDAQ:GILD
138.5B USD 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.1B USD -136.5
US
Epizyme Inc
F:EPE
94.1B EUR -440.6
AU
CSL Ltd
ASX:CSL
121.8B AUD 54.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.7B USD 20
US
Seagen Inc
F:SGT
39.3B EUR -60.6
NL
argenx SE
XBRU:ARGX
33.1B EUR -107.1
 
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/FCFE: 30.9
Negative Multiple: -63.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 114 076.7
US
Abbvie Inc
NYSE:ABBV
16.3
US
Amgen Inc
NASDAQ:AMGN
51.2
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -136.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -440.6
AU
CSL Ltd
ASX:CSL
54.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -107.1

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A